In vitro Macro-and Microautoradiographic Localization of V1 and V2 Receptors in the Rat Kidney Using OPC-21268 and OPC-31260

Nephron

Volumn 76, Issue 3, 1997, Pages 331-336

  Mimura, Yukari ^a   Ogura, Toshio ^a   Hayakawa, Nobuhiko ^a   Otsuka, Fumio ^a   Hashimoto, Masami ^a   Yamauchi, Takayoshi ^a   Makino, Hirofumi ^a   Ogawa, Norio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Autoradiography; Kidney; OPC 21268; OPC 31260; V1 receptor; V2 receptor; Vasopressin

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; ANGIOTENSIN; MOZAVAPTAN; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; EMULSION; GLOMERULUS; KIDNEY; KIDNEY BLOOD VESSEL; KIDNEY CORTEX; KIDNEY INTERSTITIUM; KIDNEY MEDULLA; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE ASSAY; RAT; RECEPTOR BINDING;

ANIMALS; AUTORADIOGRAPHY; BENZAZEPINES; KIDNEY; LIGANDS; MALE; PIPERIDINES; QUINOLONES; RATS; RATS, WISTAR; RECEPTORS, VASOPRESSIN; TISSUE DISTRIBUTION; TRITIUM; VASOPRESSINS;

EID: 0030748290     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190200     Document Type: Article

References (22)

1. Frindl G, Burg MB: Effect of vasopressin on sodium transport in renal cortical collecting tubules, Kidney Int 1972:1:224-231.
2. McNeill JR: Role of vasopressin in the control of arterial pressure, Can J Physiol Pharmacol 1983;61:1226-1235.
3. Share L: Role of vasopressin in cardiovascular regulation, Physiol Rev 1988:68:1248-1284.
4. Kirk CJ, Michell RH: Phosphalidylinositol metabolism in rat hcpatocytes stimulated by vasopressin, Biochem J 1981;194:155-165.
5. Van Leeuwen FW, van der Beek EM, van Heerikhuize JJ, Wolters P, van der Muelen G, Wan Y-P: Quantitative light microscopic autoradiographic localization of binding sites labeled with ['H]d(CH:)5Tyr(Me)VP in the rat brain, pituitary and kidney, Brain Res 1987.80: 121-126.
6. Xiaomei Li, Andreas K, Wicder ED, Phoebe T, Ncmenoff RA, Schrier RW: Inhibition of vasopressin action in vascular smooth muscle by the V, antagonist OPC-21268. Hypertension 1994:23:217-222.
7. rvas-cular vasopressin receptors, Regul Pcpt 1992; 38:1-11.
8. Michell RH, Kirk CJ, Billah MM: Hormonal stimulation of phosphalidylinositol breakdown with particular reference to the hepatic effects of vasopressin, Biochem Soc Trans I979;7: 861-865.
9. Phillips PA, Kelly JM, Abrahams JM, Zbigniew G, George P, Mendelsohn FAO, Johnston Cl: Vasopressin receptors in rat brain and kidney: Studies using a radio-iodinated V receptor antagonist, J Hypertens 1988;6(suppl 4): 550-553.
10. Ando Y, Tabei K, Asano Y: Luminal vasopressin modulates transport in the rabbit in the cortical collecting duct, J Clin Invest 1991:88: 952-959.
11. Butlen D, Guillon G, Rajerison RM, Jard S, Sawyer WH, Manning M: Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and competitive inhibitors, Mol Pharmacol 1978:14: 1006-1017.
12. Mitsui T, Ogura T, Ogawa N, Ota Z: Reduction of specific arginine vasopressin binding sites of renal medulla membranes in lithium treated rats, Res Commun Chem Pathol Pharmacol 1985:50:201-208.
13. Ogura T, Mitsui T, Yamamoto I, Kalayama E, Ota Z, Ogawa N: Differential changes in atrial natriuretic peptide and vasopressin receptor bindings in kidney of spontaneously hypertensive rat, Life Sci l’986;40:233-238.
14. Nishida N, Ogura T, Yamauchi T, Hosoya M, Ota Z: Treatment with cilazapril, angiotensin-converting enzyme inhibitor, changes the affinity of arginine vasopressin receptor in the kidney of the spontaneously hypertensive rat, Res Commun Chem Pathol Pharmacol 1994:84: 143-152.
15. Yamamura Y, Ogawa H, Chihara T, Kondo K, Onogawa T, Nakamura S, Mori T, Tominaga M, Yabuuchi Y: OPC-21268. an orally effective, nonpcptide vasopressin V, receptor antagonist, Science 1991:252:572-574.
16. Yamamura Y, Ogawa H, Yamashita H, Chihara T, Miyamoto H, Nakamura S, Onogawa T, Yamashita T, Hosokawa T, Mori T, Tominaga M, Yabuuchi Y: Characterization of a novel aquaretic agent, OPC-31260. as an orally effective, nonpcptide vasopressin Vi receptor antagonist, BrJ Pharmacol 1992:105:787-791.
17. Takatori K, Ogura T, Ota Z: Computerized approach using autoradiography to quantify atrial natriuretic peptide receptors in the DOCA-salt hypertensive rat kidney, Regul Pept 1991:35: 115-125.
18. Yamada Y, Yamamura Y, Chihara T, Onogawa T, Nakamura S, Yamashita T, Mori T, Tominaga M, Yabuuchi Y: OPC-21268. a vasopressin V antagonist, produces hypotension in spontaneously hypertensive rats, Hypertension 1994:23:200-204.
19. Yamamoto I, Ogura T, Ota Z: In vitro macro-autoradiographic localization of atrial natriuretic peptide in the rat kidney, Res Commun Chen Pathol Pharmacol 1987;56:185-198.
20. WUthrich RP, Vallotton MB: Prostaglandin E? and cyclic AMP response to vasopressin in renal medullary tubular cells, Am J Physiol 1986.251:F499-F505.
21. Yamauchi T, Ogura T, Oishi T, Harada K, Hashimoto M, Mimura Y, Asano N, Ola Z, Kageyama J: Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin V, receptors, Acta Med Okayama 1995;49:53-59.
22. Mimura Y, Ogura T, Yamauchi T, Otsuka F, Oishi T, Harada K, Hashimoto M, Ota Z: Elfect of vasopressin V, and V receptor stimulation on blood pressure in DOCA-salt-hyper-lensive rats, Acta Med Okayama 1995:49:187-194.